The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.

Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing.

The MarketWatch News Department was not involved in the creation of this content. Nation's largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates ...

Total spending on health care in the United States is expected to climb from $3 trillion to over $4 trillion annually by the end of the decade, and while that may mean sales growth for a lot of health ...

They're the two biggest pharmacy benefits managers in the world, and they compete against each other every day. While CVS Health boasts a higher market cap thanks to its retail pharmacies, Express ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

Anthem CEO Joseph Swedish said if Express Scripts — the nation’s largest manager of prescription drug benefits — doesn’t give Anthem more money in savings, the insurer might look for another pharmacy ...

Cigna signed a definitive agreement to acquire Express Scripts for $67 billion in cash and stock, including assumption of $15 billion in Express Scripts debt. Here are five things to know about the ...

Hours after a class-action lawsuit was filed in Cambria County court, on behalf of Martella's Pharmacies and its customers, a judge has ordered a temporary hold on the PBM Express Scripts and its plan ...

Michigan Attorney General Dana Nessel filed a lawsuit against Express Scripts and Prime Therapeutics last week, claiming the two pharmacy benefit managers allegedly engaged in anticompetitive conduct ...